Maestro
Payments companies reported to CMS as associated with Maestro. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Maestro, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Maestro
These are the largest totals companies reported as associated with Maestro. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ana Franceschi | Manhasset, NY | Neuroradiology | $1,500.00 |
| Gautam Prasad | Dublin, CA | Radiation Oncology | $1,500.00 |
| Ravikumar Patel | Hershey, PA | Diagnostic Radiology | $1,000.00 |
| Dane Cohen | Sewell, NJ | Radiation Oncology | $1,000.00 |
| Shyam Tanguturi | Boston, MA | Radiation Oncology | $1,000.00 |
| Michael Morris | Glen Burnie, MD | Diagnostic Radiology | $500.00 |
| Daniel Noorollah | New York, NY | Oral and Maxillofacial Surgery | $108.46 |
| Jay Shiao | Kansas City, KS | Radiation Oncology | $103.00 |
| John Keating | Pueblo, CO | Orthodontics and Dentofacial Orthopedics | $101.64 |
| John Jarboe | Montgomery, AL | Radiation Oncology | $99.00 |
Prescribed Maestro?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.